#USA #Quest Diagnostics #Secaucus #Lyme Disease #Tick-Borne Pathogens

New Insights into Lyme Disease and Co-Infections

A recent study conducted by Quest Diagnostics, in collaboration with the University of North Carolina at Chapel Hill, has yielded significant findings about Lyme disease and its association with other tick-borne pathogens. Published in the JAMA Network Open, the study involved testing over 193,000 individuals across the United States who were assessed for tick-borne diseases between January 2021 and December 2025. This extensive research is believed to be the largest of its kind in the U.S., focusing on the simultaneous evaluation of multiple tick-borne infections.

Key Findings

According to the study, approximately 29.5% of participants who exhibited antibodies against Borrelia burgdorferi, the bacterium responsible for Lyme disease, also tested positive for antibodies against other tick-borne pathogens. In stark contrast, only 5.5% of those without Lyme disease antibodies showed signs of co-infection. The most prevalent co-infections identified were with Babesia microti and Anaplasma phagocytophilum, known to be transmitted by the blacklegged tick, the primary vector for Lyme disease.

Emily I. Schindler, MD, PhD, Medical Director of Infectious Disease Immunology at Quest Diagnostics, emphasized the importance of these findings. She stated, "The results highlight a frequent clinical reality of co-exposure to multiple pathogens, especially in regions endemic to Lyme disease. This underscores the need for comprehensive testing to ensure accurate treatment."

Geographic Insights

The regional analysis revealed that patients from the Northeastern U.S. were particularly susceptible to co-infections, with 31.1% of those testing positive for Lyme disease also having antibodies against other pathogens. In comparison, the prevalence of co-infections was significantly lower in the Midwest (16.6%), South (16.0%), and West (13.6%) regions. The findings align with increasing ticks' presence due to factors such as warmer temperatures and rising populations of deer and mice, which are common hosts for ticks.

Seasonal Patterns

The analysis also showed a clear seasonal pattern regarding diagnostic testing, with more than 40% of all tests conducted during the summer months, and nearly 26% in the fall, which corresponds with peak tick activity. Most of the tested patients (70.6%) were from the Northeast, further emphasizing the geographical trends observed in tick-borne diseases.

The study reported that the Centers for Disease Control and Prevention (CDC) estimates that approximately 476,000 individuals are diagnosed with Lyme disease annually in the U.S. This disease can lead to serious complications if left untreated, affecting joints, the heart, and even the nervous system. The standard treatment involves antibiotics such as doxycycline; however, co-infections like Babesia, which do not respond to these antibiotics, necessitate unique treatment approaches.

Conclusions and Implications

The findings from the Quest Diagnostics study provide essential evidence for the need to broaden our approach to testing and treatment of tick-borne illnesses. As highlighted by Yonghong Li, PhD, the lead author, the substantial rate of antibody co-detection demonstrates a pressing need for clinicians to consider co-infection scenarios seriously. This research not only contributes to the understanding of Lyme disease but also lays the groundwork for future studies on tick-borne diseases.

In conclusion, as the landscape for tick-borne pathogens evolves, the healthcare community must adapt to ensure optimal patient care. Comprehensive testing strategies could significantly improve diagnostic accuracy and treatment effectiveness, ultimately reducing the long-term impact of these diseases on public health.

Quest Diagnostics continues to lead the way in laboratory testing solutions and emphasizes the necessity of awareness and precision in addressing tick-borne illnesses. For those at risk, understanding the prevalence of co-infections could be key to ensuring timely and effective healthcare interventions.